实用医学杂志 ›› 2023, Vol. 39 ›› Issue (6): 747-751.doi: 10.3969/j.issn.1006⁃5725.2023.06.016

• 药物与临床 • 上一篇    下一篇

糖皮质激素对重症药物性肝损伤的疗效分析及剂量选择 

张丹丹 徐峰 李娅 宋锐锋 刘琳    

  1. 郑州大学第一附属医院消化内三科(郑州450052)

  • 出版日期:2023-03-25 发布日期:2023-03-25

Efficacy and dose selection of glucocorticoid for severe drug ⁃induced liver injury

ZHANG Dandan*,XU Feng,LI Ya,SONG Ruifeng,LIU Lin.    

  1. Department of Gastroenterology,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China 

  • Online:2023-03-25 Published:2023-03-25

摘要:

目的 探讨糖皮质激素对重症药物性肝损伤患者的疗效及剂量选择。方法 收集 2018 9 月至 2021 8 月于郑州大学第一附属医院就诊的 232 例重症药物性肝损伤患者资料,根据病程中是否使用糖皮质激素及其剂量分为:激素组(进一步分为< 0.5 mg/(kg·d)组和≥ 0.5 mg/(kg·d)组)和对照组, 并比较激素组与对照组间、不同剂量激素组间 ALT、AST、DBIL、IBIL、TBIL 疗效差异及并发症分析。 结果 (1)激素组与对照组间住院时间差异有统计学意义(P < 0.05),激素组为 18.00(13.00,24.00)d,对照组为 21.00(15.00,29.00)d。激素组与对照组间 AST、DBIL、IBIL、TBIL 较基线下降 30%、50%所需时间差 异有统计学意义(P < 0.05),ALT 较基线下降 30%、50%所需时间差异无统计学意义(P > 0.05)。(2)不同 剂量激素组间 AST、ALT、DBIL、IBIL、TBIL 较基线值降低 30%、50%所需时间差异无统计学意义(P > 0.05)。(3)激素组与对照组间、不同剂量激素组间感染相关不良反应差异有统计学意义(P < 0.05)。 结论 糖皮质激素联合常规保肝药物能更快改善重症药物性肝损伤患者 AST、DBIL、IBIL、TBIL 水平, 不同剂量糖皮质激素对 ALT、AST、DBIL、IBIL、TBIL 的疗效无明显差异,但当激素组剂量≥ 0.5 mg/(kg· d)时,感染发生率更高。

关键词:

重症药物性肝损伤, 糖皮质激素, 疗效, 剂量

Abstract:

Objective To investigate the efficacy and dose selection of glucocorticoid in severe drug⁃ induced liver injury. Methods Data of 232 patients with severe drug ⁃induced liver injury who admitted to The First Affiliated Hospital of Zhengzhou University hospital from September 2018 to August 2021 were collected. According to the use of glucocorticoid and their dose during the course of disease,they were divided into hormone group(further divided into < 0.5 mg/(kg·d)group and ≥ 0.5 mg/(kg·d)group)and control group. The efficacy of ALT,AST,DBIL,IBIL,TBIL and complication were analyzed,between hormone group and control group,different dose of hormone group. Results (1)The mean hospital stay between the hormone group and the control group was statistically different(P < 0.05),the number of days of hospitalization in the hormone group was 18.00(13.00 24.00)days,and that in the control group was 21.00(15.00,29.00)days. There was statistical difference between two group in the time required for the reduction of AST,DBIL,IBIL and TBIL by 30% and 50% compared with the baseline value(P < 0.05). There was no statistical difference between two group in the time required for the reduction of ALT by 30% and 50% compared with the baseline value(P > 0.05).(2)The days of ALT,AST DBIL,IBIL and TBIL decrased by 30%,50% compared with the baseline value in the different doses of hormone group was no statistically difference(P > 0.05).(3)There were statistically difference in infection⁃related adverse reactions between the hormone group and the control group,and between different doses of hormone group(P < 0.05). Conclusion Glucocorticoid combined with conventional liver ⁃ protecting drugs can improve the levels of AST DBIL,IBIL and TBIL in the patients with severe drug⁃induced liver injury. There was no statistical difference in the improved of ALT,AST and TBIL with different doses of glucocorticoid,but when the dose of hormone group was ≥ 0.5 mg/(kg·d),the incidence of infection was higher. 

Key words:

severe drug?induced liver injury, glucocorticoid, efficacy, dose